![Akihiko Shimauchi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Akihiko Shimauchi
Directeur/Membre du Conseil chez CHORDIA THERAPEUTICS INC.
Postes actifs de Akihiko Shimauchi
Sociétés | Poste | Début | Fin |
---|---|---|---|
CHORDIA THERAPEUTICS INC. | Independent Dir/Board Member | 01/10/2022 | - |
Directeur/Membre du Conseil | 01/10/2022 | - | |
Comptroller/Controller/Auditor | 01/01/2018 | 01/10/2022 | |
INDEE Medical, Inc.
![]() INDEE Medical, Inc. Medical SpecialtiesHealth Technology INDEE Medical, Inc. engages in the manufacture and sale of medical related products. It distributes ReCell, a treatment kit that creates cell suspension once sprayed or applied on wounds with damage. It is also being used for scars, vitiligo, nevus, leg ulcers, and in cosmetic surgery. The company was founded in January 2016 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
Fondateur | - | - | |
President | - | - |
Historique de carrière de Akihiko Shimauchi
Anciens postes connus de Akihiko Shimauchi
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ortho-Clinical Diagnostics KK | Directeur/Membre du Conseil | - | - |
Sales & Marketing | - | - | |
Fujirebio, Inc.
![]() Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | President | - | - |
American Hospital Supply Corp. | Corporate Officer/Principal | - | - |
AJINOMOTO CO., INC. | Corporate Officer/Principal | - | - |
Quintiles Transnational Japan K.K.
![]() Quintiles Transnational Japan K.K. Pharmaceuticals: MajorHealth Technology Part of Quintiles Transnational Corp., Quintiles Transnational Japan K.K. is a Japanese company that manufactures and distributes pharmaceutical drugs and provides training services for medical professionals. The company is based in Tokyo, Japan. Yoh Narimatsu has been the CEO of the company since 2006. | Corporate Officer/Principal | - | - |
M's Science Corp.
![]() M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | President | 31/03/2009 | - |
Formation de Akihiko Shimauchi
Waseda University | Undergraduate Degree |
Statistiques
Internationale
Japon | 9 |
Etats-Unis | 2 |
Opérationnelle
President | 3 |
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Sectorielle
Health Technology | 6 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
AJINOMOTO CO., INC. | Consumer Non-Durables |
CHORDIA THERAPEUTICS INC. | Health Technology |
Entreprise privées | 6 |
---|---|
M's Science Corp.
![]() M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Commercial Services |
Quintiles Transnational Japan K.K.
![]() Quintiles Transnational Japan K.K. Pharmaceuticals: MajorHealth Technology Part of Quintiles Transnational Corp., Quintiles Transnational Japan K.K. is a Japanese company that manufactures and distributes pharmaceutical drugs and provides training services for medical professionals. The company is based in Tokyo, Japan. Yoh Narimatsu has been the CEO of the company since 2006. | Health Technology |
American Hospital Supply Corp. | Health Technology |
Fujirebio, Inc.
![]() Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Health Technology |
Ortho-Clinical Diagnostics KK | |
INDEE Medical, Inc.
![]() INDEE Medical, Inc. Medical SpecialtiesHealth Technology INDEE Medical, Inc. engages in the manufacture and sale of medical related products. It distributes ReCell, a treatment kit that creates cell suspension once sprayed or applied on wounds with damage. It is also being used for scars, vitiligo, nevus, leg ulcers, and in cosmetic surgery. The company was founded in January 2016 and is headquartered in Tokyo, Japan. | Health Technology |
- Bourse
- Insiders
- Akihiko Shimauchi
- Expérience